SCHEMBL6480799

SCHEMBL6480799

Nc1ccnc(-c2ccc3cccnc3c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASIC3 Q9UHC3 3/20 0.54
ALDH1A1 P00352 4/20 0.50
CASP1 P29466 2/20 0.50
HTT P42858 2/20 0.50
KDM4E B2RXH2 1/20 0.50
TP53 P04637 1/20 0.50
HSP90AA1 P07900 1/20 0.50
HSP90AB1 P08238 1/20 0.50
MAPT P10636 1/20 0.50
TSHR P16473 1/20 0.50
ATM Q13315 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CASP7 P55210 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
NR4A2 P43354 1/20 0.46
NPC1 O15118 5/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6034300 0.81 ALDH1A1 (0.46) ALDH1A1CASP1HTTMEN1KMT2A
SCHEMBL28084480 0.80 ALDH1A1 (0.56) ALDH1A1CASP1HTTKDM4ETP53
SCHEMBL31121089 0.80 ALDH1A1 (0.52) ALDH1A1CASP1HTTKDM4ETP53
SCHEMBL9838799 0.80 ALDH1A1 (0.52) ALDH1A1CASP1HTTKDM4ETP53
SCHEMBL6033038 0.79 ASIC3 (0.53) ASIC3ALDH1A1CASP1HTTKDM4E
SCHEMBL30045789 0.79 ALDH1A1 (0.70) ALDH1A1CASP1HTTKDM4ETP53
SCHEMBL118900 0.79 ALDH1A1 (0.70) ALDH1A1CASP1HTTKDM4ETP53
SCHEMBL3726615 0.78 NPC1 (0.68) ALDH1A1CASP1HTTKDM4ETP53
SCHEMBL29485612 0.78 NPC1 (0.68) ALDH1A1CASP1HTTKDM4ETP53
SCHEMBL24150219 0.78 EGFR (0.63) ASIC3KDM4ENPC1RAB9AIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101035780-A Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain MERCK SHARP & DOHME (GB) 2007-09-12 CN disclosed
US-20050197342-A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain HOLLINGWORTH GREGORY J (GB) 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197342-A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain OPRL1, OPRK1, CNR1 ASIC3 294/4885ALDH1A1 2879/4885CASP1 2377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.